A Phase Ii Evaluation of Nintedanib (Bibf-1120) in the Treatment of Recurrent or Persistent Endometrial Cancer: An Nrg Oncology/Gynecologic Oncology Group Study

AuthID
 P-00V-T6C
8
Author(s)
Dizon D.S.
·
Sill M.W.
·
Schilder J.M.
·
McGonigle K.F.
·
Rahman Z.
·
Mutch D.G.
·
Leslie K.K.
Document Type
Article
Year published
2014
Published
in Gynecologic Oncology, ISSN: 0090-8258
Volume: 135, Issue: 3, Pages: 441-445 (4)
Indexing
Scopus®
Crossref®53
Pubmed®
Google Scholar®
Publication Identifiers
Pubmed: 25312396
Scopus: 2-s2.0-84920741562
Source Identifiers
ISSN: 0090-8258
Export Publication Metadata
Marked List
 Add to Marked List
Info
At this moment we don't have any links to full text documens.

footer slogan

Useful Links

Get Help

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service